Our proven quant model uses 115 proprietary factors, including AI, to determine ORKT's potential to beat the market
ORKT doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ORKT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ORKT ($3.13) is overvalued by 1,024.82% relative to our estimate of its Fair Value price of $0.28 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ORKT ($3.13) is not significantly undervalued (1,024.82%) relative to our estimate of its Fair Value price of $0.28 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
(NASDAQ: ORKT) Orangekloud Technology trades on the NASDAQ under the ticker symbol ORKT. Orangekloud Technology stock quotes can also be displayed as NASDAQ: ORKT.
What is the 52 week high and low for Orangekloud Technology (NASDAQ: ORKT)?
(NASDAQ: ORKT) Orangekloud Technology's 52-week high was $8.00, and its 52-week low was $1.45. It is currently -60.88% from its 52-week high and 115.86% from its 52-week low.
How much is Orangekloud Technology's stock price per share?
(NASDAQ: ORKT) Orangekloud Technology stock price per share is $3.13 today (as of Nov 29, 2024).
What is Orangekloud Technology's Market Cap?
(NASDAQ: ORKT) Orangekloud Technology's market cap is $71.21M, as of Dec 2, 2024.
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.
Orangekloud Technology's market cap is calculated by multiplying ORKT's current stock price of $3.13 by ORKT's total outstanding shares of 22,750,000.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.